Medicheck Info Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 12-07-2024
- Paid Up Capital ₹ 1.80 Cr
as on 12-07-2024
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 6.90 Cr
as on 12-07-2024
- Revenue -44.96%
(FY 2019)
- Profit -53.73%
(FY 2019)
- Ebitda -7.67%
(FY 2019)
- Net Worth 2.22%
(FY 2019)
- Total Assets 2.03%
(FY 2019)
About Medicheck Info
The Corporate was formerly known as Mediline Pharmaceuticals (India) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.80 Cr.
The company currently has active open charges totaling ₹6.90 Cr.
Nisha Asrani, Raza Sayyed, and Hitesh Asrani serve as directors at the Company.
- CIN/LLPIN
U24230MH2003PTC142873
- Company No.
142873
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 2003
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medicheck Info?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nisha Asrani  | Director | 08-Apr-2013 | Current |
| Raza Sayyed | Additional Director | 08-Apr-2019 | Current |
| Hitesh Asrani | Director | 27-Oct-2003 | Current |
Financial Performance and Corporate Structure Insights of Medicheck Info.
Medicheck Info Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 44.96% decrease. The company also saw a substantial fall in profitability, with a 53.73% decrease in profit. The company's net worth moved up by a moderate rise of 2.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medicheck Info?
In 2019, Medicheck Info had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Crp Beaumont Research (India) Private LimitedActive 12 years 4 monthsRaza Sayyed and Hitesh Asrani are mutual person
Crp Risk Management LimitedActive 24 years 9 monthsNisha Asrani, Raza Sayyed and 1 more are mutual person
Apple Lifecare (India) Private LimitedActive 21 years 1 monthNisha Asrani and Hitesh Asrani are mutual person
- White Eagle Copyrights Private LimitedActive 3 years 5 months
Raza Sayyed and Hitesh Asrani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Dec 2016 | ₹6.90 Cr | Open |
How Many Employees Work at Medicheck Info?
Unlock and access historical data on people associated with Medicheck Info, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicheck Info, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicheck Info's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
